Global H1N1 Vaccines Market Thrives: Intramuscular Segment and Hospital Pharmacies at the Forefront
A recent report by Research and Markets forecasts significant growth in the Global H1N1 Vaccines Market until 2028. This comprehensive analysis explores industry... Read more.
Dark Side of Alendronic Acid: Unveiling the 10 Worst Side Effects
Alendronic acid, a bisphosphonate medication used primarily for the treatment of osteoporosis, was not discovered by a single individual. Instead, it was developed... Read more.
Is Lecithin Bad For You?
In the intricate world of dietary components, lecithin often stands as an enigmatic figure. Found in various foods and commonly utilized in food production, lecithin... Read more.
Is Bitter Melon Bad for Your Kidneys?
Bitter melon, also known as Momordica charantia or bitter gourd, has been a staple in traditional medicine for centuries, celebrated for its potential health benefits.... Read more.
What is Cannabinoid Hyperemesis Syndrome (CHS)?
Cannabis, often regarded as a therapeutic and recreational substance, has witnessed a surge in popularity and acceptance in recent years. However, amidst the debates... Read more.
Examples Of Nondihydropyridine Calcium Channel Blockers & Their Side Effects
Nondihydropyridine calcium channel blockers (NDHP CCBs) constitute a critical class of pharmaceutical agents employed predominantly in the management of cardiovascular... Read more.
10 Super Supplements That Help with Brain Zaps
The human brain, with its approximately 86 billion neurons interconnected by trillions of synapses, is an intricate network that governs every aspect of our existence.... Read more.
Novartis Reports Positive 48-Week Results for Fabhalta in PNH Trial
Novartis Pharmaceuticals Corporation has released new 48-week results from the Phase III APPLY-PNH trial, showcasing sustained efficacy and long-term safety of Fabhalta®... Read more.
Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment
Danish biotech company, Hoba Therapeutics, has successfully secured EUR 23 million (USD 25 million) in a Series A financing first close. The funding round was co-led... Read more.
Medtronic and Cosmo Pharmaceuticals Propel Healthcare Forward with AI-Driven Care Collaboration
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has announced a definitive agreement to expand its partnership with Cosmo Intelligent Medical... Read more.